The federal HIPAA compliance audit program won't resume until this fall at the soonest, says Susan McAndrew of the HHS Office for Civil Rights. She describes specific steps that organizations can take to prepare.
Intel has added privacy to the portfolio of its top information security executive, Malcolm Harkins, who says too many information security professionals are "color blind or tone deaf" to privacy, wrongly thinking strong data protection provides privacy safeguards.
As hospitals and clinics plow ahead with their HIPAA Omnibus Rule compliance efforts, they should also remind patients to be careful when communicating their own health information. A clinical psychologist offers practical insights.
The National Institutes of Health is tackling security challenges as it rolls out many "big data" research endeavors involving human genomes and other sensitive data. Research director Eric Green describes the issues.
The health advocacy group Genetic Alliance on April 5 will unveil a registry designed to enable patients to control how health information is shared with researchers. Spokesman Greg Biggers discusses privacy measures.
Getting inspectors general and agencies' IT security heads to agree on how best to evaluate information security should strengthen U.S. federal government agencies' risk management frameworks, say former OMB leaders Karen Evans and Franklin Reeder.
Complying with the HIPAA Omnibus Rule requires a task force approach, says John Pritchard, information security manager at St. Charles Health System. Find out why Pritchard believes the rule eliminates ambiguities.
American Express confirms it was hit this week by a distributed-denial-of-service attack. The hacktivist group that has targeted banks in recent months claims credit for this latest high-profile attack.
Attacks against Facebook, Twitter and other organizations over the past few months should send a message to business owners that they need to better fund cybersecurity, IT security expert Mischel Kwon says.
The new Aurora Research Institute is taking multiple steps to protect the privacy of patients who participate in medical research, clinical trials and personalized medicine endeavors, says institute leader Randall Lambrecht.